Mark O'connor JR. in Sterling, Massachusetts

Medical School: University Of Massachusetts Medical School
Graduation Year: 2012
The Primary Medical Specialty for Mark O'connor JR. is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 12
PAC (PECOS ID)#: 0547486326
NPI #: 1215297270
NPI Created On: 05/24/2012
NPI Last Updated Listed as: 05/14/2019
Primary Taxonomy Code: 207RC0000X
License Number:
277574
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
7. Heart rhythm tracing of 48-hour ekg
8. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
9. Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
10. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
11. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
12. Remote evaluations of defibrillator up to 90 days with analysis, review and report
13. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
14. Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days
15. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
16. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
17. Follow-up or limited ultrasound examination of heart
18. Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
19. Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers
20. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function